Structure-Based Discovery of Mouse Trace Amine-Associated Receptor 5 Antagonists
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: 10.1021/acs.jcim.3c00755
- Ereignis
-
Veröffentlichung
- (wo)
-
Aachen
- (wer)
-
Universitätsbibliothek der RWTH Aachen
- (wann)
-
2023
- Urheber
-
Nicoli, Alessandro
Weber, Verena
Bon, Carlotta
Steuer, Alexandra
Gustincich, Stefano
Gainetdinov, Raul R.
Lang, Roman
Espinoza, Stefano
Di Pizio, Antonella
- DOI
-
10.18154/RWTH-2024-01461
- URN
-
urn:nbn:de:101:1-2407170132593.289298099771
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:50 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Nicoli, Alessandro
- Weber, Verena
- Bon, Carlotta
- Steuer, Alexandra
- Gustincich, Stefano
- Gainetdinov, Raul R.
- Lang, Roman
- Espinoza, Stefano
- Di Pizio, Antonella
- Universitätsbibliothek der RWTH Aachen
Entstanden
- 2023
Ähnliche Objekte (12)
Structure-Based Development of Selective Orexin 1 Receptor Antagonists
Biomolecular simulations in structure-based drug discovery
Structure-based development of secondary amines as aspartic protease inhibitors
Structure-based design for the discovery of novel ligands targeting the FMN riboswitch
Controlling Hyperglycemia: Discovery of Novel Small α-Amylase Inhibitors Using Structure-Based Virtual Screening
Human trace amine-associated receptor TAAR5 can be activated by trimethylamine
Trace amine-associated receptor 1 is involved in various aspects of endocrine regulation
Trace amine-associated receptor 1 (TAAR1) is a positive prognosticator for epithelial ovarian cancer
Discovery of a non-canonical prototype long-chain monoacylglycerol lipase through a structure-based endogenous reaction intermediate complex
Structure-based design of hyaluronidase inhibitors
Discovery and optimization of the first PqsR antagonists as anti-virulence agents combating Pseudomonas aeruginosa infections
Structure-based virtual screening using index technology
Structure-Based Development of Selective Orexin 1 Receptor Antagonists
Biomolecular simulations in structure-based drug discovery
Structure-based development of secondary amines as aspartic protease inhibitors
Structure-based design for the discovery of novel ligands targeting the FMN riboswitch
Controlling Hyperglycemia: Discovery of Novel Small α-Amylase Inhibitors Using Structure-Based Virtual Screening
Human trace amine-associated receptor TAAR5 can be activated by trimethylamine
Trace amine-associated receptor 1 is involved in various aspects of endocrine regulation
Trace amine-associated receptor 1 (TAAR1) is a positive prognosticator for epithelial ovarian cancer
Discovery of a non-canonical prototype long-chain monoacylglycerol lipase through a structure-based endogenous reaction intermediate complex
Structure-based design of hyaluronidase inhibitors
Discovery and optimization of the first PqsR antagonists as anti-virulence agents combating Pseudomonas aeruginosa infections
Structure-based virtual screening using index technology
Structure-Based Development of Selective Orexin 1 Receptor Antagonists
Biomolecular simulations in structure-based drug discovery
Structure-based development of secondary amines as aspartic protease inhibitors
Structure-based design for the discovery of novel ligands targeting the FMN riboswitch
Controlling Hyperglycemia: Discovery of Novel Small α-Amylase Inhibitors Using Structure-Based Virtual Screening
Human trace amine-associated receptor TAAR5 can be activated by trimethylamine
Trace amine-associated receptor 1 is involved in various aspects of endocrine regulation
Trace amine-associated receptor 1 (TAAR1) is a positive prognosticator for epithelial ovarian cancer
Discovery of a non-canonical prototype long-chain monoacylglycerol lipase through a structure-based endogenous reaction intermediate complex
Structure-based design of hyaluronidase inhibitors
Discovery and optimization of the first PqsR antagonists as anti-virulence agents combating Pseudomonas aeruginosa infections